Diacomit(Stiripentol) Side Effects

Common adverse reactions (≥10% incidence) include somnolence, decreased appetite, ataxia, weight loss, hypotonia, nausea, tremor, and insomnia.  

Frequent and Serious Adverse Events  

In clinical trials, somnolence (67%), appetite loss (45%), agitation (27%), ataxia (27%), and weight loss (27%) were predominant. Serious risks include neutropenia (13%), thrombocytopenia (13%), and suicidality (class-wide AED warning). Gastrointestinal effects (nausea, vomiting) and neurologic symptoms (dysarthria, tremor) are notable. Rare events include aggression and salivary hypersecretion. Long-term data show similar safety profiles in infants ≥6 months. Overdose management is supportive; no antidote exists. Drug interactions (e.g., elevated clobazam/norclobazam levels) require vigilant monitoring.

Stiripentol(Diacomit)
Stiripentol is indicated for the treatment of seizures associated with Dravet syndrome (severe myoclonic epilepsy in infants) in patients aged 6 months and older, weighing 7 kg or...
RELATED ARTICLES
What are the adverse reactions of Stiripentol(Diacomit)?

As an anti-epileptic drug, stiripentol has been recognized by the majority of patients for its therapeutic effect....

Thursday, July 3rd, 2025, 15:35
/ 1
1 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved